Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    WYDASE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Akorn Pharmaceuticals

    02 1Amphastar Pharmaceuticals

    03 2Bausch & Lomb Incorporated

    04 1Central Procurement & Supplies Unit

    05 2Genentech

    06 1Halozyme Therapeutics

    07 6JANSSEN BIOTECH

    08 1Pinewood Healthcare

    09 6Takeda Pharmaceutical

    10 1Viatris

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Akorn Pharmaceuticals

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Akorn Pharmaceuticals

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    HYALURONIDASE

    Brand Name : HYDASE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : 150 UNITS/ML

    Packaging :

    Approval Date :

    Application Number : 21716

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Amphastar Pharmaceuticals

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Amphastar Pharmaceuticals

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    HYALURONIDASE

    Brand Name : AMPHADASE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : 150 UNITS/ML

    Packaging :

    Approval Date :

    Application Number : 21665

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Bausch & Lomb Incorporated

    Canada
    PEGS Boston Summit
    Not Confirmed
    arrow

    Bausch & Lomb Incorporated

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    HYALURONIDASE

    Brand Name : VITRASE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : 6,200 UNITS/VIAL

    Packaging :

    Approval Date :

    Application Number : 21640

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Bausch & Lomb Incorporated

    Canada
    PEGS Boston Summit
    Not Confirmed
    arrow

    Bausch & Lomb Incorporated

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    HYALURONIDASE

    Brand Name : VITRASE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : 200 UNITS/VIAL

    Packaging :

    Approval Date :

    Application Number : 21640

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Genentech

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Genentech

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

    Brand Name : PHESGO

    Dosage Form : INJECTABLE;SUBCUTANEOUS

    Dosage Strength : 1,200MG;600MG;30,000UNITS

    Packaging :

    Approval Date :

    Application Number : 761170

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Genentech

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Genentech

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

    Brand Name : PHESGO

    Dosage Form : INJECTABLE;SUBCUTANEOUS

    Dosage Strength : 600MG;600MG;20,000UNITS

    Packaging :

    Approval Date :

    Application Number : 761170

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Halozyme Therapeutics

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Halozyme Therapeutics

    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    HYALURONIDASE RECOMBINANT HUMAN

    Brand Name : HYLENEX RECOMBINANT

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : 150 UNITS/ML

    Packaging :

    Approval Date :

    Application Number : 21859

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    JANSSEN BIOTECH

    Country
    PEGS Boston Summit
    Not Confirmed
    arrow

    JANSSEN BIOTECH

    Country
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    DARATUMUMAB AND HYALURONIDASE-FIHJ

    Brand Name : DARZALEX FASPRO

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : 120MG;2000UNITS/ML

    Packaging :

    Approval Date :

    Application Number : 761145

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    JANSSEN BIOTECH

    Country
    PEGS Boston Summit
    Not Confirmed
    arrow

    JANSSEN BIOTECH

    Country
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    AMIVANTAMAB AND HYALURONIDASE-LPUJ

    Brand Name : RYBREVANT FASPRO

    Dosage Form : INJECTION

    Dosage Strength : 14ML

    Packaging :

    Approval Date :

    Application Number : 761433

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    JANSSEN BIOTECH

    Country
    PEGS Boston Summit
    Not Confirmed
    arrow

    JANSSEN BIOTECH

    Country
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    AMIVANTAMAB AND HYALURONIDASE-LPUJ

    Brand Name : RYBREVANT FASPRO

    Dosage Form : VIAL; SINGLE-USE

    Dosage Strength : 1,600MG/20,000 UNITS PER 10ML

    Packaging :

    Approval Date :

    Application Number : 761484

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    JANSSEN BIOTECH

    Country
    PEGS Boston Summit
    Not Confirmed
    arrow

    JANSSEN BIOTECH

    Country
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    AMIVANTAMAB AND HYALURONIDASE-LPUJ

    Brand Name : RYBREVANT FASPRO

    Dosage Form : VIAL; SINGLE-USE

    Dosage Strength : 2,240MG/28,000 UNITS PER 14ML

    Packaging :

    Approval Date :

    Application Number : 761484

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    JANSSEN BIOTECH

    Country
    PEGS Boston Summit
    Not Confirmed
    arrow

    JANSSEN BIOTECH

    Country
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    AMIVANTAMAB AND HYALURONIDASE-LPUJ

    Brand Name : RYBREVANT FASPRO

    Dosage Form : VIAL; SINGLE-USE

    Dosage Strength : 2,400MG/30,000 UNITS PER 15ML

    Packaging :

    Approval Date :

    Application Number : 761484

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    JANSSEN BIOTECH

    Country
    PEGS Boston Summit
    Not Confirmed
    arrow

    JANSSEN BIOTECH

    Country
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    AMIVANTAMAB AND HYALURONIDASE-LPUJ

    Brand Name : RYBREVANT FASPRO

    Dosage Form : VIAL; SINGLE-USE

    Dosage Strength : 3,5200MG/44,000 UNITS PER 22ML

    Packaging :

    Approval Date :

    Application Number : 761484

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Pinewood Healthcare

    Ireland
    PEGS Boston Summit
    Not Confirmed
    arrow

    Pinewood Healthcare

    Ireland
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorised

    Registration Country : Malta

    Hyaluronidase

    Brand Name : Hyalase

    Dosage Form : Powder For Solution For Injection And Infusion

    Dosage Strength : 1500IU/ML

    Packaging :

    Approval Date : 2006-08-23

    Application Number :

    Regulatory Info : Authorised

    Registration Country : Malta

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Takeda Pharmaceutical

    Japan
    PEGS Boston Summit
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Denmark

    Hyaluronidase; Normalt Immunoglobulin Til Intravenøs Brug; Humant

    Brand Name : Hyqvia

    Dosage Form : Infusion Solution

    Dosage Strength : 100mg/ml

    Packaging :

    Approval Date : 16-05-2013

    Application Number : 28104990111

    Regulatory Info : Prescription

    Registration Country : Denmark

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Takeda Pharmaceutical

    Japan
    PEGS Boston Summit
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    HYALURONIDASE (HUMAN RECOMBINANT)

    Brand Name : HYQVIA

    Dosage Form : SOLUTION

    Dosage Strength : 200UNIT/1.25ML

    Packaging :

    Approval Date :

    Application Number : 2524368

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Takeda Pharmaceutical

    Japan
    PEGS Boston Summit
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    HYALURONIDASE (HUMAN RECOMBINANT)

    Brand Name : HYQVIA

    Dosage Form : SOLUTION

    Dosage Strength : 400UNIT/2.5ML

    Packaging :

    Approval Date :

    Application Number : 2524376

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Takeda Pharmaceutical

    Japan
    PEGS Boston Summit
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    HYALURONIDASE (HUMAN RECOMBINANT)

    Brand Name : HYQVIA

    Dosage Form : SOLUTION

    Dosage Strength : 800UNIT/5ML

    Packaging :

    Approval Date :

    Application Number : 2524384

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Takeda Pharmaceutical

    Japan
    PEGS Boston Summit
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    HYALURONIDASE (HUMAN RECOMBINANT)

    Brand Name : HYQVIA

    Dosage Form : SOLUTION

    Dosage Strength : 1600UNIT/10ML

    Packaging :

    Approval Date :

    Application Number : 2524392

    Regulatory Info : SCHEDULE D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Central Procurement & Supplies Unit

    Country
    PEGS Boston Summit
    Not Confirmed
    arrow

    Central Procurement & Supplies Unit

    Country
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Invalid

    Registration Country : Malta

    Hyaluronidase

    Brand Name : Hyalase

    Dosage Form : Powder For Solution For Injection And Infusion

    Dosage Strength : 1500IU

    Packaging :

    Approval Date : 2019-04-29

    Application Number :

    Regulatory Info : Invalid

    Registration Country : Malta

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.